€
7. 71
+0.15
+1.9841%
€
134.32M Market Cap
- P/E Ratio
2% Div Yield
75 Volume
0 Eps
€ 7.56
Previous Close Want to track 4G8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
4G8 closed Friday higher at €7.71, an increase of 1.9841% from Thursday's close, completing a monthly decrease of -9.6131% or -€0.82. Over the past 12 months, 4G8 stock lost -45.5508%.
4G8 is not paying dividends to its shareholders.
The last earnings report, released on Mar 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Guerbet SA has completed 1 stock splits, with the recent split occurring on Jan 23, 2014.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XMUN (EUR).
Guerbet SA (4G8) FAQ
What is the stock price today?
The current price is €7.71.
On which exchange is it traded?
Guerbet SA is listed on XFRA.
What is its stock symbol?
The ticker symbol is 4G8.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2%.
What is its market cap?
As of today, the market cap is 134.32M.
Has Guerbet SA ever had a stock split?
Guerbet SA had 1 splits and the recent split was on Jan 23, 2014.
Guerbet SA Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Philippe Bourrinet CEO | XFRA Exchange | FR0000032526 ISIN |
| France Country | 2,653 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Guerbet SA is a pioneering company dedicated to the development and marketing of diagnostic and interventional imaging solutions worldwide. Established in 1926, the company has consistently been at the forefront of the imaging field, offering a wide range of contrast media products, delivery systems, medical devices, and related solutions. Headquartered in Villepinte, France, Guerbet SA is committed to advancing medical imaging technology to improve patient diagnosis and treatment, with a strong emphasis on innovation, particularly in the realms of MRI, CT, and Cath Lab consumables and digital solutions.
Products and Services
Guerbet SA's product lineup is diverse, covering different aspects of medical imaging and treatment. Here are some of their key offerings:
- Optiray and Xenetix: These are non-ionic, monomeric, and iodinated contrast agents used in various imaging procedures to improve clarity and detail.
- Telebrix Gastro: A meglumine ioxitalamate solution designed for gastrointestinal imaging.
- Conray: An iothalamate meglumine injection used for enhancing diagnostic images.
- Micropaque/Microtrast: A diagnostic imaging interconnected solution, which enhances the visualization of specific body parts during imaging procedures.
- Dotarem and Artirem: Gadoteric acid-based products acting as MRI contrast agents, facilitating clearer imaging of internal structures.
- Prefilled Syringes, Injectors, Accessories, and Consumables: For MRI, CT, and Cath Lab procedures, these products ensure efficient delivery of contrast media and seamless imaging processes.
- Digital Solutions:
- Contrast&Care: An injection management solution that optimizes the use and tracking of contrast media.
- Dose&Care: An X-ray dose management solution that helps control and reduce patients' exposure to radiation.
- icobrain: A cloud-based AI solution that supports the quantification of disease-specific brain structures on MR and CT scans, aiding in the diagnosis and treatment of acute and chronic neurological conditions.
- Interventional Radiology Products: Including Lipiodol, Vectorio, Patent Blue V, Axessio, and SeQure and DraKon microcatheters for targeted treatment and diagnostic procedures in interventional radiology.
- Hydra Vision: A digital imaging system designed for use in urological, gastroenterological, and gynecological treatments, as well as for planning and diagnostic procedures.
- Urology Accessories and Consumables: Specialized tools and products to support urological procedures and treatments.
Contact Information
Address: 15 rue des Vanesses
Phone: 33 1 45 91 50 00
Website: https://www.guerbet.com
